Cargando…
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
BACKGROUND: Studies have reminded that cardiovascular metabolic comorbidities made patients more susceptible to suffer 2019 novel corona virus (2019-nCoV) disease (COVID-19), and exacerbated the infection. The aim of this analysis is to determine the association of cardiovascular metabolic diseases...
Autores principales: | Li, Bo, Yang, Jing, Zhao, Faming, Zhi, Lili, Wang, Xiqian, Liu, Lin, Bi, Zhaohui, Zhao, Yunhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087935/ https://www.ncbi.nlm.nih.gov/pubmed/32161990 http://dx.doi.org/10.1007/s00392-020-01626-9 |
Ejemplares similares
-
Hypertension May Reduce the Infection Risk but Increase the Severity of COVID-19: Based on the Current Data in China
por: Li, Bo, et al.
Publicado: (2021) -
The impact of COVID-19 pandemic on the treatment of acute appendicitis in China
por: Zheng, ZhiXue, et al.
Publicado: (2021) -
Impact of cardiovascular and metabolic diseases on the severity of COVID-19: a systematic review and meta-analysis
por: Meng, Meng, et al.
Publicado: (2020) -
The prevalence of metabolic syndrome and cardiovascular risk factors in adults in southern China
por: Lao, Xiang Qian, et al.
Publicado: (2012) -
Exploring the impact of the COVID-19 epidemic on the medical emergency calls and calls for cardiovascular diseases in Hangzhou, China
por: Chen, Juan, et al.
Publicado: (2021)